Aberrant expression of SOCS1 and SOCS3 has been described in human colorectal cancer, where SOCS3 overexpression inhibits proliferation, migration and invasiveness of tumor cells [57], while SOCS1 overexpression has pro-oncogenic activity [58]. The gene discussed is SOCS1; the disease is neoplasm.